Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Eligard 22,5 mg poeder en oplosmiddel voor oplossing voor injectie
Disc Medicine
Patients with biochemical recurrence after primary treatment of prostate cancer presenting with =<4 metastases
1 trial -
Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat, Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat
Genzyme Europe B.V.
Gaucher's disease type I; Gaucher's disease type III
1 trial -
Eliquis 5 mg film-coated tablets, ACETYLSALICYLIC ACID
Pari Pharma GmbH
Aortic bioprothesis implanted patient for valvular heart disease
1 trial -
Eltrombopag 25 MG Oral Tablet
The First People's Hospital of Lianyungang
Stem Cell Transplant Complications
1 trial -
Emixustat
BRIGHT MINDS BIOSCIENCES INC.
Stargardt Disease
1 trial -
Empagliflozin
Boehringer Ingelheim
Myocardial Infarction
1 trial -
Empagliflozin 10 mg
United Therapeutics Europe Ltd
Acute Myocardial Infarction
1 trial -
Empliciti 400 mg powder for concentrate for solution for infusion., DARZALEX 1800 mg solution for injection, Alnuctamab, Imnovid 2 mg hard capsules, Alnuctamab, Imnovid 3 mg hard capsules, Imnovid 1 mg hard capsules, Kyprolis 60 mg powder for solution for infusion, Fortecortin® Inject 8 mg Injektionslösung in einer Ampulle, DEXAMETHASONE, Imnovid 4 mg hard capsules
Celgene Europe Limited
Relapsed and/or Refractory Multiple Myeloma
1 trial -
Empowered Relief On-Demand
BRIGHT MINDS BIOSCIENCES INC.
Chronic Pain
1 trial -
Enbrel 50 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe
Mabxience Research SL
Rheumatoid Arthritis
1 trial -
Enbrel 50 mg solution for injection in pre-filled syringe, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Guselkumab 1 mL PFS Placebo, Guselkumab, Guselkumab 0.5 mL Varioject Placebo, Enbrel 25 mg powder and solvent for solution for injection
Janssen-Cilag International N.V.
Chronic Plaque Psoriasis
1 trial -
Encaleret
BridgeBio Oncology Therapeutics
Autosomal Dominant Hypocalcemia Type 1 (ADH1)
1 trial -
Encaleret
BridgeBio Oncology Therapeutics
Autosomal Dominant Hypocalcemia (ADH)
2 trials -
Endoscopic submucosal dissection
Chinese University of Hong Kong
Colorectal Neoplasms
1 trial -
Endoscopic submucosal dissection
United Therapeutics Europe Ltd
Colorectal Neoplasms
1 trial -
Enema transplant of fecal microbiota, Placebo Enema transplant of fecal microbiota
Pari Pharma GmbH
Adult patients with ulcerative colitis diagnosed for at least 3 months
1 trial -
Enhanced care
BRIGHT MINDS BIOSCIENCES INC.
Drug Addiction
1 trial -
Enhanced standard management
United Therapeutics Europe Ltd
Pacemaker Complication
1 trial -
Enoxaparin sodium (XRP4563)
Sanofi Pasteur
Myocardial Infarction
1 trial -
Entyvio 108 mg solution for injection in pre-filled syringe, Entyvio 108 mg solution for injection in pre-filled pen
Takeda
Ulcerative Colitis or Crohn’s Disease
1 trial -
Entyvio 108 mg solution for injection in pre-filled syringe, Entyvio 300 mg powder for concentrate for solution for infusion
Takeda
Active Ulcerative Colitis or Crohn’s Disease
1 trial -
Enzastaurin
AYTU BIOPHARMA, INC
Vascular Ehlers-Danlos Syndrome
1 trial -
Epcoritamab (GEN3013), Revlimid 5 mg hard capsules, Revlimid 20 mg hard capsules, Epcoritamab (GEN3013), Truxima 500 mg concentrate for solution for infusion, Truxima 100 mg concentrate for solution for infusion
AbbVie Deutschland GmbH & Co. KG
Relapsed and Refractory Follicular Lymphoma
1 trial -
Epidyolex 100 mg/ml oral solution
Lacuna Pharma Pty Ltd
Dravet Syndrome, Tuberous sclerosis complex, Lennox-Gastaut Syndrome
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources